Miconazol Saar (Miconazole Nitrate)

Miconazole nitrate blocks the fungal enzyme lanosterol 14α‑demethylase, a key step in the synthesis of ergosterol, an essential component of fungal cell membranes. By preventing ergosterol formation, the drug disrupts membrane integrity, leading to increased permeability and ultimately halting fungal growth and replication.

The specific dose and frequency of Miconazol Saar are determined by the prescribing healthcare professional based on the type and severity of the infection, the patient’s age, and the area of skin involved. Patients should follow the prescriber’s instructions and the product label for proper application.

Safety data for topical miconazole nitrate in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Miconazol Saar.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials. After verification, the team provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Miconazol Saar belongs to the imidazole class, which offers broad‑spectrum activity against dermatophytes, yeasts and some molds. Compared with allylamine agents such as terbinafine, imidazoles like miconazole have a slightly slower onset but are effective for a wide range of superficial infections and are available in many topical formulations.

Miconazol Saar should be stored at room temperature below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keeping the product sealed helps maintain its stability and potency throughout its shelf life.

The medication is applied directly to the affected skin area, usually twice daily, unless otherwise directed by a healthcare professional. The skin should be clean and dry before application, and hands should be washed after use to avoid accidental spread to other body sites.

While rare, serious adverse reactions can include severe allergic responses such as angioedema, anaphylaxis, or extensive contact dermatitis. If signs of a serious reaction appear—such as swelling of the face, difficulty breathing, or widespread rash—use should be stopped immediately and medical attention sought.

Miconazol Saar should not be used on broken, severely inflamed, or infected skin without medical advice, and it is contraindicated in individuals with a known hypersensitivity to miconazole nitrate or any other component of the formulation. Patients with extensive skin conditions should consult a healthcare professional before use.